Author:
Fleischhacker E.,Trentzsch H.,Kuppinger D.,Piltz S.,Beyer F.,Meigel F.,Kammerer T.,Rehm M.,Hartl W. H.
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine,Emergency Nursing,Emergency Medicine,Internal Medicine
Reference50 articles.
1. Wiedermann CJ, Eisendle K (2017) Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European Medicines Agency. J Pharm Policy Pract 10:12
2. European Medicines Agency (2018) https://www.ema.europa.eu/en/news/hydroxyethyl-starch-solutions-cmdh-introduces-new-measures-protect-patients . Accessed April 10, 2019
3. European Medicines Agency (2018) Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients. https://www.ema.europa.eu/documents/referral/hydroxyethyl-starch-article-107i-referral-hydroxyethyl-starch-solutions-cmdh-introduces-new-measures_en.pdf . Accessed April 10, 2019
4. Bellomo R, Bion J, Finfer S, Myburgh J, Perner A, Reinhart K (2014) Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth 112(3):595–600
5. Coriat P, Guidet B, de Hert S, Kochs E, Kozek S, Van Aken H (2014) Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth 113(1):194–195
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Substanzen zur Flüssigkeitstherapie und Outcome – ein Update;AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie;2021-04